Cargando...
Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy
The biggest hurdle to targeted cancer therapy is the inevitable emergence of drug resistance. Tumor cells employ different mechanisms to resist the targeting agent. Most commonly in EGFR-mutant non-small cell lung cancer, secondary resistance mutations on the target kinase domain emerge to diminish...
Gardado en:
| Publicado en: | J Hematol Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6902404/ https://ncbi.nlm.nih.gov/pubmed/31815659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0818-2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|